Literature DB >> 22828098

Breast cancer screening: clinical, radiologic, and biochemical.

Elizabeth D Feldman1, Bridget A Oppong, Shawna C Willey.   

Abstract

Breast cancer screening is a highly complex and more recently a controversial topic. Conventional screening includes breast self-examination, clinical breast examination, and screening mammography. Several newer imaging modalities have been introduced into the screening armamentarium including breast magnetic resonance imaging and whole-breast automated ultrasound. Novel imaging techniques like positron emission mammography are currently under clinical investigation in the hopes of improving the sensitivity of breast cancer screening. In addition, the development of biochemical assays, which employ minimally invasive sampling are also promising.

Entities:  

Mesh:

Year:  2012        PMID: 22828098     DOI: 10.1097/GRF.0b013e31825ca884

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  2 in total

1.  Clinical utility of positron emission mammography.

Authors:  Shannon B Glass; Zeeshan A Shah
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-07

2.  Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.

Authors:  Peadar S Waters; Roisin M Dwyer; Cathy Brougham; Claire L Glynn; Deirdre Wall; Peter Hyland; Maria Duignan; Mark McLoughlin; John Newell; Michael J Kerin
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.